Basic information
Investigator: MUDr. Tomáš Páleníček, PhD.
Main recipient: ACADEMISCH ZIEKENHUIS GRONINGEN
Co-recipient: National Institute of Mental Health (NIMH)NUDZ and partners
Research period: 1/1/2024 – 31/12/2027
Total budget: 160,405,342 CZK
NIMH budget: 13,482,625 CZK
Supported by: : Funded by the European Union
Annotation
This study will examine whether psilocybin therapy can help alleviate psychological and existential distress in palliative care patients suffering from one of four different incurable progressive diseases: advanced chronic obstructive pulmonary disease (COPD), multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and atypical Parkinson’s disease (APD).